| Scrip Code | 543331 |
|---|---|
| NSE Symbol | MOL |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0CT101020 |
| Name of company | MEGHMANI ORGANICS LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 04-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 04-11-2026 12:00:00 |
| End date and time of board meeting | 04-11-2026 13:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 66,691.63 | 1,20,974.58 | |
| Other income | 2,007.44 | 3,199.97 | |
| Total income | 68,699.07 | 1,24,174.55 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 44,055.11 | 74,158.33 |
| (b) | Purchases of stock-in-trade | 676.32 | 2,393.75 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (2,733.95) | (5,546.22) |
| (d) | Employee benefit expense | 3,627.54 | 6,995.30 |
| (e) | Finance costs | 1,496.96 | 2,802.09 |
| (f) | Depreciation, depletion and amortisation expense | 3,028.75 | 6,008.61 |
| (f) | Other Expenses | ||
| 1 | Other Expnese | 13,752.99 | 25,868.84 |
| Total other expenses | 13,752.99 | 25,868.84 | |
| Total expenses | 63,903.72 | 1,12,680.70 | |
| 3 | Total profit before exceptional items and tax | 4,795.35 | 11,493.85 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 4,795.35 | 11,493.85 |
| 6 | Tax expense | ||
| 7 | Current tax | 1,281.38 | 3,090.85 |
| 8 | Deferred tax | 125.58 | 195.14 |
| 9 | Total tax expenses | 1,406.96 | 3,285.99 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 3,388.39 | 8,207.86 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | (0.16) | (0.25) |
| 16 | Total profit (loss) for period | 3,388.23 | 8,207.61 |
| 17 | Other comprehensive income net of taxes | 26.68 | 50.80 |
| 18 | Total Comprehensive Income for the period | 3,414.91 | 8,258.41 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 3,388.23 | 8,207.61 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 3,414.91 | 8,258.41 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2,543.14 | 2,543.14 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 1.33 | 3.23 | |
| Diluted earnings (loss) per share from continuing operations | 1.33 | 3.23 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 1.33 | 3.23 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 1.33 | 3.23 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 1,44,542.20 | |
| Capital work-in-progress | 7,988.50 | |
| Investment property | 0.00 | |
| Goodwill | 0.00 | |
| Other intangible assets | 1,258.41 | |
| Intangible assets under development | 923.64 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 356.87 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| 1 | Security Deposits | 338.48 |
| 2 | Bank Deposits with original maturity of more than 12 months (including interest accrued) | 697.76 |
| 3 | Goverment Grant Receivable | 452.84 |
| Total of other non-current financial assets | 1,489.08 | |
| Total non-current financial assets | 1,845.95 | |
| Deferred tax assets (net) | 0.00 | |
| Other non-current assets | ||
| 1 | Capital Advances | 185.10 |
| 2 | Balances with Government Authorities | 6,708.60 |
| 3 | Advance payment of Income Tax and TDS (Net of Provision) | 1,086.77 |
| Total of other non-current assets | 7,980.47 | |
| Total non-current assets | 1,64,539.17 | |
| 2 | Current assets | |
| Inventories | 56,795.30 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 87,126.49 | |
| Cash and cash equivalents | 920.14 | |
| Bank balance other than cash and cash equivalents | 835.42 | |
| Loans, current | 37.14 | |
| Other current financial assets | ||
| Total of other current financial assets | 3,046.93 | |
| Total current financial assets | 91,966.12 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Balance with Government Authorities - GST Credit (net) | 4,213.00 |
| 2 | Advances to Suppliers | 272.25 |
| 3 | Prepaid Expenses | 285.66 |
| 4 | Export Benefit Receivable | 1,246.83 |
| 5 | Employee's Imprest | 45.31 |
| Total of other current assets | 6,063.05 | |
| Total current assets | 1,54,824.47 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 3,19,363.64 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 2,543.14 | |
| Other equity | 1,60,198.98 | |
| Total equity attributable to owners of parent | 1,62,742.12 | |
| Non controlling interest | 0.00 | |
| Total equity | 1,62,742.12 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 11,260.30 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| Total of other non-current financial liabilities | ||
| Total non-current financial liabilities | 11,260.30 | |
| Provisions, non-current | 2,678.01 | |
| Deferred tax liabilities (net) | 5,741.99 | |
| Deferred government grants, Non-current | 485.19 | |
| Other non-current liabilities | ||
| Total of other non-current liabilities | ||
| Total non-current liabilities | 20,165.49 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 55,161.99 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 945.09 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 66,043.22 | |
| Total Trade payable | 66,988.31 | |
| Other current financial liabilities | ||
| 1 | Interest accrued but not due on borrowings | 297.64 |
| 2 | Employee Benefits Payable | 4,331.80 |
| 3 | Payable for Unclaimed Dividend | 35.80 |
| 4 | Payable for retention money | 486.32 |
| 5 | Payable for Capital Goods | 819.15 |
| 6 | Security Deposits Payable | 650.74 |
| 7 | Mark to Market Liabilities on derivative instruments | 1,337.51 |
| Total of other current financial liabilities | 7,958.96 | |
| Total current financial liabilities | 1,30,109.26 | |
| Other current liabilities | 1,330.69 | |
| 1 | Advance from Customers | 538.13 |
| 2 | Statutory dues payable | 201.03 |
| 3 | Other Payable | 591.53 |
| Total of other current liabilities | 1,330.69 | |
| Provisions, current | 265.02 | |
| Current tax liabilities (Net) | 4,751.06 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 1,36,456.03 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 1,56,621.52 | |
| Total equity and liabilites | 3,19,363.64 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Pigment | 18,728.33 | 33,086.28 | ||||
| 2 | Agrochemicals | 49,675.00 | 88,836.37 | ||||
| 3 | Others | 2,140.33 | 5,313.99 | ||||
| Total Segment Revenue | 70,543.66 | 1,27,236.64 | |||||
| Less: Inter segment revenue | 3,852.03 | 6,262.06 | |||||
| Revenue from operations | 66,691.63 | 1,20,974.58 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Pigment | 726.54 | 1,011.51 | ||||
| 2 | Agrochemicals | 5,313.99 | 12,319.96 | ||||
| 3 | Others | 310.06 | 1,012.16 | ||||
| Total Profit before tax | 6,350.59 | 14,343.63 | |||||
| i. Finance cost | 1,496.96 | 2,802.09 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 58.44 | 47.94 | |||||
| Profit before tax | 4,795.19 | 11,493.60 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Pigment | 1,13,791.82 | 1,13,791.82 | ||||
| 2 | Agrochemicals | 1,95,798.94 | 1,95,798.94 | ||||
| 3 | Others | 18,977.61 | 18,977.61 | ||||
| Total Segment Asset | 3,28,568.37 | 3,28,568.37 | |||||
| Un-allocable Assets | (9,204.73) | (9,204.73) | |||||
| Net Segment Asset | 3,19,363.64 | 3,19,363.64 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Pigment | 24,769.22 | 24,769.22 | ||||
| 2 | Agrochemicals | 54,773.24 | 54,773.24 | ||||
| 3 | Others | 4,457.03 | 4,457.03 | ||||
| Total Segment Liabilities | 83,999.49 | 83,999.49 | |||||
| Un-allocable Liabilities | 72,622.03 | 72,622.03 | |||||
| Net Segment Liabilities | 1,56,621.52 | 1,56,621.52 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement Gain on Define Benefit Plans | 33.10 | 66.22 |
| Total Amount of items that will not be reclassified to profit and loss | 33.10 | 66.22 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 8.32 | 16.64 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Foreign Currency Translation Reserve on Translation of Foreign Subsidiary | 2.54 | 1.63 |
| Total Amount of items that will be reclassified to profit and loss | 2.54 | 1.63 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.64 | 0.41 |
| 5 | Total Other comprehensive income | 26.68 | 50.80 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 11,493.85 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 2,802.09 | |||||
| Adjustments for decrease (increase) in inventories | (3,940.52) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (22,649.24) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (56.44) | |||||
| Adjustments for decrease (increase) in other non-current assets | 442.06 | |||||
| Adjustments for other financial assets, non-current | 422.11 | |||||
| Adjustments for other financial assets, current | (291.27) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 13,925.85 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 51.28 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 6,008.61 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 383.48 | |||||
| Adjustments for other financial liabilities, current | 804.05 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 1,492.20 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 798.39 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 31.95 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 214.25 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | (1,157.93) | |||||
| Net cash flows from (used in) operations | 10,335.92 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | (755.08) | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 11,091.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 145.97 | |||||
| Purchase of property, plant and equipment | 3,192.12 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 796.71 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 244.70 | |||||
| Net cash flows from (used in) investing activities | (2,004.74) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 6,179.65 | |||||
| Payments of lease liabilities | 0.00 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 3,567.51 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (9,747.16) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (660.90) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (660.90) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 1,581.04 | |||||
| Cash and cash equivalents cash flow statement at end of period | 920.14 | |||||